Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aloe Plus (also known as Habb-e-sabr-e-Razi) is an over-the-counter (OTC) herbal tablet developed and manufactured by Niak. Based on the traditional Persian medicine formulation 'Habb-e-Sabr', it is primarily indicated for the treatment of acute and chronic constipation, as well as for improving digestive function, cleansing bile, and relieving abdominal and menstrual pain. The formulation contains a combination of active botanical ingredients, including Aloe vera dried latex (Sabr-e-Zard), yellow myrobalan (Terminalia chebula), turpeth (Operculina turpethum), mastic (Pistacia lentiscus), and damask rose (Rosa damascena). The primary active components, anthraquinones (such as aloin A and B) from the Aloe vera latex, act as stimulant laxatives by inhibiting water reabsorption in the colon and stimulating peristaltic movements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aloe Plus.